Related Experiment Video
Updated: Aug 19, 2026
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Therapeutic node dissections in malignant melanoma
1State University of New York at Buffalo, Millard Fillmore Health System, 14209, USA.
Abstract:
In the absence of distant disease, therapeutic node dissections in malignant melanoma, i.e., dissections of regional nodal basins for palpable suspicious or biopsy-proven positive nodes, offer the chance of cure. The 5-year survival rates after therapeutic lymphadenectomy closely correlate with expected cure rates. Although they varied greatly in the literature, from 19% to 38%, the currently obtainable survival rates are in the upper ranges of this spectrum because patients now are closely followed-up and operated for early palpable nodal disease. Properly done, these procedures carry a low morbidity, but they should be done thoroughly to completely eradicate regional disease and avoid recurrences in the same nodal basin to achieve the maximum survival that is surgically attainable.
Insights
Therapeutic node dissections for malignant melanoma offer a chance of cure when distant disease is absent. Thorough dissections improve survival rates by eradicating regional disease and preventing recurrence.
Area of Science:
- Oncology
- Surgical Oncology
- Dermatology
Background:
- Therapeutic node dissections are crucial for potentially curative treatment in malignant melanoma patients without distant metastasis.
- Regional nodal basins are key sites for melanoma spread, making lymphadenectomy a critical intervention.
Purpose of the Study:
- To evaluate the role and outcomes of therapeutic node dissections in achieving cure for malignant melanoma.
- To correlate survival rates with the thoroughness of lymphadenectomy and early detection of nodal disease.
Main Methods:
- Review of therapeutic lymphadenectomy procedures for palpable or biopsy-proven positive regional lymph nodes in malignant melanoma.
- Analysis of 5-year survival rates in relation to surgical management and patient follow-up protocols.
Main Results:
- 5-year survival rates after therapeutic lymphadenectomy range from 19% to 38% in historical literature.
- Current survival rates are trending towards the higher end of this spectrum due to improved patient surveillance and early surgical intervention.
- Properly performed dissections have low morbidity and are essential for complete regional disease eradication.
Conclusions:
- Therapeutic node dissections offer the best chance of cure for malignant melanoma in the absence of distant disease.
- Thorough surgical technique is paramount to maximize survival by preventing regional recurrence.
- Close patient follow-up facilitates early detection and treatment of nodal disease, improving overall outcomes.
